Clinical Trials List
Protocol NumberFHBEBAT820251219
Not yet recruiting
2026-01-01 - 2028-12-31
Phase I/II
Recruiting1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- Tien-Hua Chen Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- 戴世光 Division of Otolaryngology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
24 participants
